Pag-aaral pangklinika para sa Trangkaso sa Arizona
6 pag-aaral para sa Trangkaso ang naghahanap ng mga kalahok sa mga site sa Arizona.
Mga Lungsod sa Arizona
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
- Hope Research Institute ( Site 0575), Glendale
- Hope Research Institute ( Site 0587), Tempe
- Del Sol Research Management, LLC ( Site 0515), Tucson
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07159763A Study of Updated mRNA Seasonal Influenza Vaccines
- Arizona Clinical Trials, Tucson
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 65 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07884175Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Tucson
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05624450A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age
- GSK Investigational Site, Glendale
- GSK Investigational Site, Tucson
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT07851246A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
- GSK Investigational Site, Glendale
- GSK Investigational Site, Mesa
- GSK Investigational Site, Mesa
- at 9 pa
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 65 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07805707Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
- AMR Clinical Phoenix, Arizona- Site Number : 8400004, Tempe
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07779408Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.